The University of Queensland Centre for Clinical Research has reported they are close to moving a couple COVID-19 vaccine targets—both repurposed older drugs—to clinical trials by the end of March 2020. Professor David Paterson reports that his lab is looking at one HIV-focused drug and another, chloroquine, which was developed to treat malaria. Laboratory evidence and some progress out of China has influenced this research team’s efforts. But the investigators Down Under employ rigorous, systematic, and methodical clinical trials to verify the data.
A New Lease on Life
The focus on these two drugs potentially bring a new lease on life as their use has largely beem superseded by a newer generation of therapies, reports News.com.au in Australia. Professor Paterson at the University of Queensland Centre for Clinical Research reports that there is some evidence supporting these candidates. For example, in one case, one of the medications was given to some of the first people tested positive for COVID-19 and resulted in a complete recovery.
Can Chloroquine be used to Target COVID-19?
The Australian team looked at some observations in China where the China National Center...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).